California VC firm Aditum Bio is…
California VC firm Aditum Bio is at it again, this [...]
California VC firm Aditum Bio is at it again, this [...]
After being touted as a potential rival to Bristol Myers [...]
AGC has started a “structured process” to seek for buyers [...]
After the FDA announced it was cracking down on what [...]
Politicians scrambled to arrange the committee hearing after a string [...]
Last week, on the same day the Trump administration laid [...]
Genmab has dropped an antibody-drug conjugate picked up as part [...]
Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody [...]
After HHS secretary Robert F. Kennedy Jr. overhauled the CDC’s [...]
Forty-two years after approving the potent diuretic Bumex (bumetanide) as [...]